Onyx Scientific expands material science capabilities as part of 25th anniversary milestone: Our Bureau, Mumbai Tuesday, January 20, 2026, 15:00 Hrs [IST] Onyx Scientific, a CDMO ...

The MarketWatch News Department was not involved in the creation of this content. Bridging Bench to Bedside: De--Risking Biotherapeutic Administration via CDMO--Led Clinical--Mimic and In--Use Testing ...

Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...

In this free webinar, learn what clinical in-use studies are and why they matter for biologics safety, efficacy and CMC lifecycle. Attendees will gain insight into designing clinical in-use studies ...

A growing company in Beijing, Shuimu Dongfang is a pioneer in medical devices contract design and manufacturing outsourcing solutions for China’s expanding healthcare sector. China’s medical device ...

此前的大规模扩建无一不是在韩国，包括前段时间宣布的47亿美元扩产第三制造园区，产能落地也是在韩国总部。详见盖德视界此前报道：三星生物47亿美元“做大”，药明生物全球化“做强” 这一次，不管是随大流“象征性投资美国”，还是应对关税与客户 ...

人民财讯1月6日电，普洛药业(000739)1月6日公告，公司与西安新通药物研究股份有限公司（简称“西安新通”）于近日签订了《战略合作框架协议》，旨在开展创新药研发与外包定制生产项目（简称“CDMO项目”）的长期合作。双方开展CDMO项目的长期合作，将有 ...

Samsung Biologics CEO John Rim urged employees in a New Year message to rally as “one team” to become the world’s top contract development and manufacturing organization, as the company also marks its ...